General Information
Revision date
2020-09-03
Product name
Agilent High Sensitivity Protein 250 Reagents, Part Number 5067-1576
Emergency telephone
+(44)-870-8200418
Icons in SDS
Company Information
company name
Agilent Technologies Manufacturing GmbH & Co. KG
e-mail address of the competent person responsible for the Safety Data Sheet
pdl-msds_author@agilent.com
GHS Information
Signal word
Protein
Section 2
SECTION 2: Hazards identification
Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS]]
Product definition
Protein 250 Gel Matrix Mixture Protein 250 Destaining Mixture Solution Protein 250 Sample Mixture Buffer
CLP CLASSIFICATION
Not classified. Ingredients of unknown : Protein 250 Gel Matrix Percentage of the mixture consisting of ingredient(s) of toxicity unknown acute dermal toxicity: 10 - 30% Percentage of the mixture consisting of ingredient(s) of unknown acute inhalation toxicity: 10 - 30% Percentage of the mixture consisting of ingredient(s) of unknown acute oral toxicity: 1 - 10% Protein 250 Destaining Percentage of the mixture consisting of ingredient(s) of Solution unknown acute dermal toxicity: 1 - 10% Percentage of the mixture consisting of ingredient(s) of unknown acute inhalation toxicity: 1 - 10% Percentage of the mixture consisting of ingredient(s) of unknown acute oral toxicity: 1 - 10% Ingredients of unknown : Protein 250 Gel Matrix
Contains
4.5% of components with unknown hazards to the ecotoxicity aquatic environment Protein 250 Destaining 4.5% of components with unknown hazards to the Solution aquatic environment See Section 16 for the full text of the H statements declared above. See Section 11 for more detailed information on health effects and symptoms.
Signal word
Protein 250 Gel Matrix No signal word. Protein 250 Destaining No signal word. Solution Protein 250 Sample No signal word. Buffer
Hazard statements
Protein 250 Gel Matrix No known significant effects or critical hazards. Protein 250 Destaining No known significant effects or critical hazards. Solution Protein 250 Sample No known significant effects or critical hazards. Buffer
Prevention
Protein 250 Gel Matrix Not applicable. Protein 250 Destaining Not applicable. Solution Protein 250 Sample Not applicable. Buffer
Response
Protein 250 Gel Matrix Not applicable. Protein 250 Destaining Not applicable. Solution Protein 250 Sample Not applicable. Buffer
Storage
Protein 250 Gel Matrix Not applicable. Protein 250 Destaining Not applicable. Solution Protein 250 Sample Not applicable. Buffer
Disposal
Protein 250 Gel Matrix Not applicable. Protein 250 Destaining Not applicable. Solution Protein 250 Sample Not applicable. Buffer
Hazardous Ingredients
Protein 250 Gel Matrix Not applicable. Protein 250 Destaining Not applicable. Solution
Supplemental label elements
Protein 250 Gel Matrix Safety data sheet available on request. elements Protein 250 Destaining Safety data sheet available on request. Solution Protein 250 Sample Not applicable. Buffer Annex XVII - Restrictions : Protein 250 Gel Matrix Not applicable. on the manufacture, Protein 250 Destaining Not applicable. placing on the market Solution and use of certain Protein 250 Sample Not applicable. dangerous substances, Buffer mixtures and articles
Special packaging requirements
Tactile warning of Protein 250 Gel Matrix Not applicable. danger Protein 250 Destaining Not applicable. Solution Protein 250 Sample Not applicable. Buffer
2.3 Other hazards
Product meets the : Protein 250 Gel Matrix This mixture does not contain any substances that are criteria for PBT or vPvB assessed to be a PBT or a vPvB. according to Protein 250 Destaining This mixture does not contain any substances that are Regulation (EC) No. Solution assessed to be a PBT or a vPvB. 1907/2006, Annex XIII Protein 250 Sample This mixture does not contain any substances that are Buffer assessed to be a PBT or a vPvB. Other hazards which do : Protein 250 Gel Matrix None known. not result in Protein 250 Destaining None known.
Classifications
Solution Protein 250 Sample None known. Buffer